These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19875545)

  • 21. [Diabetes and the liver].
    Herzig S; Roden M
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1204-6. PubMed ID: 23720171
    [No Abstract]   [Full Text] [Related]  

  • 22. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.
    Cavaghan MK; Ehrmann DA; Polonsky KS
    J Clin Invest; 2000 Aug; 106(3):329-33. PubMed ID: 10930434
    [No Abstract]   [Full Text] [Related]  

  • 23. Steatohepatitis induced by intragastric overfeeding in mice.
    Deng QG; She H; Cheng JH; French SW; Koop DR; Xiong S; Tsukamoto H
    Hepatology; 2005 Oct; 42(4):905-14. PubMed ID: 16175602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose and Insulin Tolerance Tests in the Mouse.
    Vinué Á; González-Navarro H
    Methods Mol Biol; 2015; 1339():247-54. PubMed ID: 26445794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle.
    Capozza F; Combs TP; Cohen AW; Cho YR; Park SY; Schubert W; Williams TM; Brasaemle DL; Jelicks LA; Scherer PE; Kim JK; Lisanti MP
    Am J Physiol Cell Physiol; 2005 Jun; 288(6):C1317-31. PubMed ID: 15689413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topics in type 2 diabetes and insulin resistance.
    Bloomgarden ZT
    Diabetes Care; 2009 Feb; 32(2):e13-9. PubMed ID: 19171729
    [No Abstract]   [Full Text] [Related]  

  • 27. Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice.
    Sreejayan N; Dong F; Kandadi MR; Yang X; Ren J
    Obesity (Silver Spring); 2008 Jun; 16(6):1331-7. PubMed ID: 18388893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Roles of insulin receptor and insulin receptor substrates on insulin resistance].
    Ogihara T; Katagiri H; Oka Y
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():126-31. PubMed ID: 17458206
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy.
    Yang SJ; IglayReger HB; Kadouh HC; Bodary PF
    Diabetologia; 2009 May; 52(5):972-81. PubMed ID: 19277603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue.
    Lauro D; Kido Y; Castle AL; Zarnowski MJ; Hayashi H; Ebina Y; Accili D
    Nat Genet; 1998 Nov; 20(3):294-8. PubMed ID: 9806552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse models of insulin resistance and type 2 diabetes.
    Postic C; Mauvais-Jarvis F; Girard J
    Ann Endocrinol (Paris); 2004 Feb; 65(1):51-9. PubMed ID: 15122092
    [No Abstract]   [Full Text] [Related]  

  • 32. Mouse models of insulin resistance.
    Nandi A; Kitamura Y; Kahn CR; Accili D
    Physiol Rev; 2004 Apr; 84(2):623-47. PubMed ID: 15044684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: Multiple roles in multiple steps.
    Kodama Y; Brenner DA
    Hepatology; 2009 Jan; 49(1):6-8. PubMed ID: 19111006
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease.
    Aller R; de Luis DA; Izaola O; Sagrado MG; Conde R; Velasco MC; Alvarez T; Pacheco D; González JM
    Dig Dis Sci; 2009 Aug; 54(8):1772-7. PubMed ID: 19005759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of UCP1 exacerbates Western diet-induced glycemic dysregulation independent of changes in body weight in female mice.
    Winn NC; Vieira-Potter VJ; Gastecki ML; Welly RJ; Scroggins RJ; Zidon TM; Gaines TL; Woodford ML; Karasseva NG; Kanaley JA; Sacks HS; Padilla J
    Am J Physiol Regul Integr Comp Physiol; 2017 Jan; 312(1):R74-R84. PubMed ID: 27881400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of insulin-sensitising agents in mice with hepatic insulin resistance.
    Cohen SE; Tseng YH; Michael MD; Kahn CR
    Diabetologia; 2004 Mar; 47(3):407-411. PubMed ID: 14730378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling.
    Javary J; Allain-Courtois N; Saucisse N; Costet P; Heraud C; Benhamed F; Pierre R; Bure C; Pallares-Lupon N; Do Cruzeiro M; Postic C; Cota D; Dubus P; Rosenbaum J; Benhamouche-Trouillet S
    Gut; 2018 Dec; 67(12):2192-2203. PubMed ID: 29074727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC.
    Bloomgarden ZT
    Diabetes Care; 2003 Mar; 26(3):933-9. PubMed ID: 12610060
    [No Abstract]   [Full Text] [Related]  

  • 40. Non alcoholic fatty liver disease, insulin resistance, dyslipidemia and atherogenic ratios in epileptic children and adolescents on long term antiepileptic drug therapy.
    Saleh DA; Ismail MA; Ibrahim AM
    Pak J Biol Sci; 2012 Jan; 15(2):68-77. PubMed ID: 22545359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.